BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 18368067)

  • 1. ABF-1 is frequently silenced by promoter methylation in follicular lymphoma, diffuse large B-cell lymphoma and Burkitt's lymphoma.
    Ushmorov A; Leithäuser F; Ritz O; Barth TF; Möller P; Wirth T
    Leukemia; 2008 Oct; 22(10):1942-4. PubMed ID: 18368067
    [No Abstract]   [Full Text] [Related]  

  • 2. KLF4 is a tumor suppressor in B-cell non-Hodgkin lymphoma and in classic Hodgkin lymphoma.
    Guan H; Xie L; Leithäuser F; Flossbach L; Möller P; Wirth T; Ushmorov A
    Blood; 2010 Sep; 116(9):1469-78. PubMed ID: 20519630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic and molecular genetic studies in the diagnosis of B-cell lymphomas I: mantle cell lymphoma, follicular lymphoma, and Burkitt's lymphoma.
    Campo E
    Hum Pathol; 2003 Apr; 34(4):330-5. PubMed ID: 12733111
    [No Abstract]   [Full Text] [Related]  

  • 4. Frequent DNA methylation but not mutation of the ID4 gene in malignant lymphoma.
    Hagiwara K; Nagai H; Li Y; Ohashi H; Hotta T; Saito H
    J Clin Exp Hematop; 2007 Apr; 47(1):15-8. PubMed ID: 17510533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequent epigenetic silencing of protocadherin 10 by methylation in multiple haematologic malignancies.
    Ying J; Gao Z; Li H; Srivastava G; Murray PG; Goh HK; Lim CY; Wang Y; Marafioti T; Mason DY; Ambinder RF; Chan AT; Tao Q
    Br J Haematol; 2007 Mar; 136(6):829-32. PubMed ID: 17341268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of ARG protein expression in mature B cell lymphomas compared to non-neoplastic reactive lymph node.
    Kabiri Z; Salehi M; Mokarian F; Mohajeri MR; Mahmoodi F; Keyhanian K; Doostan I; Ataollahi MR; Modarressi MH
    Cell Immunol; 2009; 259(2):111-6. PubMed ID: 19604504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The intron enhancer of the immunoglobulin kappa gene activates c-myc but does not induce the Burkitt-specific promoter shift.
    Polack A; Strobl L; Feederle R; Schweizer M; Koch E; Eick D; Wiegand H; Bornkamm GW
    Oncogene; 1991 Nov; 6(11):2033-40. PubMed ID: 1945409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitor of DNA binding 4 functions as a tumor suppressor and is targetable by 5-aza-2'-deoxycytosine with potential therapeutic significance in Burkitt's lymphoma.
    Gao XZ; Zhao WG; Wang GN; Cui MY; Zhang YR; Li WC
    Mol Med Rep; 2016 Feb; 13(2):1269-74. PubMed ID: 26648013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aberrant promoter methylation in gastric lymphoma.
    Fung MK; Au WY; Liang R; Srivastava G; Kwong YL
    Haematologica; 2003 Feb; 88(2):231-2. PubMed ID: 12604419
    [No Abstract]   [Full Text] [Related]  

  • 10. [Application of gene expression profiling in molecular classification, prognosis and therapy of B-cell lymphoma].
    Mao ZR; Zhou R; Zhang XX; Mueller-Hermelink Hk; Rosenwald A
    Zhonghua Bing Li Xue Za Zhi; 2009 Nov; 38(11):785-9. PubMed ID: 20079025
    [No Abstract]   [Full Text] [Related]  

  • 11. The gray zone between Burkitt's lymphoma and diffuse large B-cell lymphoma from a genetics perspective.
    Salaverria I; Siebert R
    J Clin Oncol; 2011 May; 29(14):1835-43. PubMed ID: 21482997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inactivation of the lamin A/C gene by CpG island promoter hypermethylation in hematologic malignancies, and its association with poor survival in nodal diffuse large B-cell lymphoma.
    Agrelo R; Setien F; Espada J; Artiga MJ; Rodriguez M; Pérez-Rosado A; Sanchez-Aguilera A; Fraga MF; Piris MA; Esteller M
    J Clin Oncol; 2005 Jun; 23(17):3940-7. PubMed ID: 15867203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A biologic definition of Burkitt's lymphoma from transcriptional and genomic profiling.
    Hummel M; Bentink S; Berger H; Klapper W; Wessendorf S; Barth TF; Bernd HW; Cogliatti SB; Dierlamm J; Feller AC; Hansmann ML; Haralambieva E; Harder L; Hasenclever D; Kühn M; Lenze D; Lichter P; Martin-Subero JI; Möller P; Müller-Hermelink HK; Ott G; Parwaresch RM; Pott C; Rosenwald A; Rosolowski M; Schwaenen C; Stürzenhofecker B; Szczepanowski M; Trautmann H; Wacker HH; Spang R; Loeffler M; Trümper L; Stein H; Siebert R;
    N Engl J Med; 2006 Jun; 354(23):2419-30. PubMed ID: 16760442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New insights into the biology of molecular subtypes of diffuse large B-cell lymphoma and Burkitt lymphoma.
    Frick M; Dörken B; Lenz G
    Best Pract Res Clin Haematol; 2012 Mar; 25(1):3-12. PubMed ID: 22409819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic sequencing studies in Burkitt's lymphoma: what can we learn about tumorigenesis?
    Soldini D; Campo E
    Expert Rev Hematol; 2013 Jun; 6(3):219-21. PubMed ID: 23782073
    [No Abstract]   [Full Text] [Related]  

  • 16. Epigenetic changes and their clinical relevance in Saudi diffuse large B-cell lymphoma. A molecular and tissue microarray analysis of 100 cases.
    Al-Kuraya KS; Siraj AK; Al-Dayel FA; Ezzat AA; Al-Jommah NA; Atizado VL; Narayanappa RN
    Saudi Med J; 2005 Jul; 26(7):1099-103. PubMed ID: 16047061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histologically transformed follicular lymphoma exhibits protein profiles different from both non-transformed follicular and de novo diffuse large B-cell lymphoma.
    Ludvigsen M; Madsen C; Kamper P; Hamilton-Dutoit SJ; Bendix K; d'Amore F; Honoré B
    Blood Cancer J; 2015 Mar; 5(3):e293. PubMed ID: 25768407
    [No Abstract]   [Full Text] [Related]  

  • 18. Loss of expression of ZAC/PLAGL1 in diffuse large B-cell lymphoma is independent of promoter hypermethylation.
    Valleley EM; Cordery SF; Carr IM; MacLennan KA; Bonthron DT
    Genes Chromosomes Cancer; 2010 May; 49(5):480-6. PubMed ID: 20175198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Re: the feasibility of gene expression profiling generated in fine-needle aspiration specimens from patients with follicular lymphoma and diffuse large B-cell lymphoma.
    Stelow EB; Hong SM; Covell JL; Moskaluk CA
    Cancer; 2007 Jun; 111(3):200-1; author reply 201-2. PubMed ID: 17520702
    [No Abstract]   [Full Text] [Related]  

  • 20. Promoter hypermethylation of the bone morphogenetic protein-6 gene in malignant lymphoma.
    Daibata M; Nemoto Y; Bandobashi K; Kotani N; Kuroda M; Tsuchiya M; Okuda H; Takakuwa T; Imai S; Shuin T; Taguchi H
    Clin Cancer Res; 2007 Jun; 13(12):3528-35. PubMed ID: 17575215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.